摘要
目的 单细胞移植治疗中晚期癌症 38例的近期临床疗效观察。方法 采用新制备的单细胞混悬液 2 50ml,细胞数 1 0 7~ 1 0 8/瓶 ,存活率 90 %以上 ,静脉输注 2 h内滴完。结果 具有减轻放疗、化疗反应 ,改善症状 ,升高白细胞 ,使癌细胞的受体花环率增加 ,而红细胞复合物 IC花环率降低作用。结论 该液治疗中晚期癌症能明显升高白细胞 ,改善放化疗的副反应 ,是利用免疫机制新探索治疗癌症的一种安全有效的生物方法。
Objective To observe short term curative effect of unicellular transplant on medium and later period cancer.Methods Within two hours, intravenous perfusion by using newly made unicellular fluid 250 ml(10 7~10 8 cells in each bottle)with a survival rate of above 90% was taken.Results The harmful effect of radioactive therapy and chemotherapy reduced, and the number of white blood cell increased. The garland rate of cancer cell went up, but that of cell complex matter IC fallen down. Conclusion Following this way to treat cancer patients can increase white cell obviously as well as reduce the harmful effect of chemotherapy and radioactive therapy. Therefore it is a safe and effective biological method to treat cancer.
出处
《中国误诊学杂志》
CAS
2001年第10期1469-1470,共2页
Chinese Journal of Misdiagnostics
关键词
中晚期癌症
单细胞移植液
红细胞C3b受体复合物
红细胞免疫复合物
medium and later period cancer
unicellular transplant
red blood cell C3b complex matter
red blood cell immunity complex matter IC